Mutations in nalc gene of Mex AB-OprM efflux pump in carbapenem resistant Pseudomonas aeruginosa isolated from burn wounds in Yazd, Iran
,
Abstract
Background and Objectives: Burn wound infections have emerged as an important cause of morbidity and mortality in patients due to prolonged hospital stay. Pseudomonas aeruginosa, is the second cause of bacterial burn wound infections. Resistance mechanisms among P. aeruginosa are intrinsic or acquired. Intrinsic resistance mechanisms among P. aeruginosa isolates are inducible AmpC cephalosporinase, decrease of specific porin OprD, and overexpression of RND efflux pump. The aim of this study was detection of mutations in nalC gene in carbapenem resistant P. aeruginosa isolated from burn wounds.
Materials and Methods: In this cross-sectional study, 180 burn-wound specimens were collected. Suspected lactose-negative colonies were identified by conventional biochemical methods. Kirby-Bauer and Etest methods were used for susceptibility testing. PCR and sequencing techniques were used for the detection of nalC mutation.
Results: Out of 180 specimens received in the laboratory, 54 of isolates were isolated and identified as P. aeroginosa (30%). Of these isolates 20 (37%) were resistant to at least two carbapenems simultaneously. From these carbapenem resistant isolates, 19 (95%), 14 (70%), 14 (70%), 19 (95%) and 16 (80%) were resistant to imipenem, cefepime, piperacillin, ceftizoxime and gentamicin, respectively. Only 1 (2%) isolate was sensitive to all carbapenems and did not has mutation in nalC gene, 20 (37%) isolates were resistant to at least two carbapenems, and had mutations in nalC gene (Gly71►Glu and Ser209►Arg).
Conclusion: As the results showed, mutation in efflux pump was observed in carbapenem resistant isolate and this confirmed that the indiscriminate use of antibiotics for treatment or prophylaxis can increase mutation in efflux pump.
2. Mirsalehian A, Nakhjavani F, Bahador A, Jabalamoli F, Beikvardi R, Goli H. Prevalence of MBL-producing Pseudomonas aeruginosa isolated from burn patients. Tehran Univ Med J 2011; 68: 563-569.
3. Quale J, Bratu S, Gupta J, Landman D. Interplay of efflux system, ampC, and oprD expression in carbapenem resistance of Pseudomonas aeruginosa clinical isolates. Antimicrob Agents Chemother 2006; 50: 1633-1641.
4. Rodríguez-Martínez JM, Poirel L, Nordmann P. Molecular epidemiology and mechanisms of carbapenem resistance in Pseudomonas aeruginosa. Antimicrob Agents Chemother 2009; 53: 4783-4788.
5. Schweizer HP. Efflux as a mechanism of resistance to antimicrobials in Pseudomonas aeruginosa and related bacteria: unanswered questions. Genet Mol Res 2003; 2: 48-62.
6. Najar Pirayeh SH, Esmaeili D. Antibiotic efflux pumps. Ann Mil Health Sci Res 2004; 2: 301-306.
7. Blair J, Piddoc L. Structure, function and inhibition of RND efflux pumps in Gram-negative bacteria. Curr Opin Microbiol 2009;12: 512-519.
8. Lister PD, Wolter DJ, Hanson ND. Antibacterial-resistant Pseudomonas aeruginosa: clinical impact and complex regulation of chromosomally encoded resistance mechanisms. Clin Microbiol Rev 2009; 22: 582-610.
9. Kumar A, Schweizer HP. Bacterial resistance to antibiotics: active efflux and reduced uptake. Adv Drug Deliv Rev 2005; 57: 1486-1513.
10. Sobel ML, Hocquet D, Cao L. Mutations in PA3574 (nalD) lead to increased MexAB-OprM expression and multidrug resistance in laboratory and clinical isolates of Pseudomonas aeruginosa. Antimicrob Agents Chemother 2005; 49: 1782-1786.
11. Chen H, Yi C, Zhang J, Zhang W, Ge Z, Yang CG, et al. Structural insight into the oxidation-sensing mechanism of the antibiotic resistance of regulator MexR. EMBO Rep 2010; 11: 685-690.
12. Daigle DM, Cao L, Fraud S, Mark S, Pacey A, Klinoski R, et al. Wilke protein modulator of multidrug efflux gene expression in Pseudomonas aeruginosa. J Bacteriol 2007; 189: 5441-5451.
13. Cao L, Srikumar R, Poole K. MexAB-OprM hyperexpression in NalC-type multidrug-resistant Pseudomonas aeruginosa: identification and characterization of the nalC gene encoding a repressor of PA3720-PA3719. Mol Microbiol 2004; 53: 1423-1436.
14. M07-A8. M07–A8. Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically; approved standard: 8th ed. CLSI 2009, Wayne, PA.
15. Pickaup W, Rhodes G, Saumders J. Moulecolar Microbial Ecology Manual, Wolters Kluwer N.V 1995; 300-300.
16. Zhang Z, Schwartz S, Wagner L, Miller W. A greedy algorithm for aligning DNA sequences. J Comput Biol 2000; 7: 203-214.
17. Evans K, Poole K. The MexA-B-OprM multidrug efflux system of Pseudomonas aeruginosa is growth phase regulated. FEMS Microbiol Lett 1999; 173: 35-39.
18. Golshani Z, Ahadi AM, Sharifzadeh A. Occurrence of ambler class B metallo-β-lactamase gene in imipenem-resistant Pseudomonas aeruginosa strains isolated from clinical samples. Zahedan J Res Med Sci 2014; 16: 6-9.
19. Wang H, Chen M, Ni Y, Liu Y, Sun H, Yu Y, et al. Antimicrobial resistance among clinical isolates from the Chinese Meropenem Surveillance Study (CMSS), 2003-2008. Int J Antimicrob Agents 2010; 35: 227-234.
20. Gill MM, Usman J, Kaleem F, Hassan A, Khalid A, Anjum R, et al. Frequency and antibiogram of multi-drug resistant Pseudomonas aeruginosa. J Coll Physicians Surg Pak 2011; 21: 531-534.
21. Sadeghifard N, Valizadeh A, Zolfaghary MR, Maleki MH, Maleki A, Mohebi R, et al. Relationship between the presence of the nalC mutation and multidrug resistance in Pseudomonas aeruginosa. Int J Microbiol 2012;2012:575193.
| Files | ||
| Issue | Vol 12 No 1 (2020) | |
| Section | Original Article(s) | |
| DOI | https://doi.org/10.18502/ijm.v12i1.2514 | |
| Keywords | ||
| Pseudomonas aeruginosa Carbapenem resistant Efflux pump nalc gene | ||
| Rights and permissions | |
|
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License. |
